Tricuspid regurgitation is notoriously hard to manage, with limited medical treatment options. What are the therapeutic options available and how can the risks to patients of treatment be reduced? Patrizio Lancellotti (Belgium) talks to Stephan Baldus (Germany) and Claudius Jacobshagen (Germany) about the Cardioband tricuspid valve...

Mitral valve repair is a fast moving field in interventional cardiology. Join Jörg Hausleiter and Ralph Stephan von Bardeleben as they talk to Volker Rudolph about the PASCAL transcatheter valve repair system, which has recently been granted a CE mark. Find out the key features that...

What are the advantages and disadvantages of using drug-coated balloons (DCBs)? What are the most important indications for these devices? Join Alexandre Abizaid, Martin B. Leon and Antonio Colombo as they discuss the latest thinking on DCB technology. Discover the benefits of using sirolimus over paclitaxel...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• to recall the unique physiology of right ventricular function
• to understand the implications of RV pressure and volume load using the pressure-volume-loop framework
• to illustrate the...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn about:

• the data supporting prognostic implications of interventional TR reduction
• the prognostic value of hemodynamic factors
• the importance of central venous congestion

1. Mortality and HF Hospitalization: Prognostic Benefit of Intervention...

Watch the interview with Ghada FARAH – Senior Vice-President, Terumo Interventional Systems who discusses about the company's participation in EuroPCR 2023.

"Education is part of our DNA" she says and EuroPCR is our annual rendezvous with healthcare professionals to engage in hands-on training. She goes on to...

In response to the challenges humanity is facing, and the community of health care professionals in particular, we are faced with a massive flow of information on all possible communication media. It can sometimes be difficult to see clearly though the constant flow of communication.

This is...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure, starting in this first episode with the hemodynamic assessment.
In this video you will learn:

• to recognize the intricate relationship between symptoms and hemodynamics in (TR-related) right heart failure.
• to...

Refine your daily practice with PCR’s E-learning, journals, online resources and Courses

If you are looking for continuing medical education on the treatment of left main and multivessel disease, you have come to the right page!  Below you will find the PCR gateways through which you can...

Embolised device complications

Embolised device complications can be classified in a variety of ways but are traditionally described either in relation to disease indication, the general phases of a procedure, or the use of specific devices. These types of complications can be life threatening, but if acting...

Maurizio Taramasso interviews Ottavio Alfieri, a pioneering figure in valve surgery and a key contributor to the development of transcatheter edge-to-edge repair, honored with the Ethica Award at the 2024 edition of #europcr. Ottavio Alfieri discusses his journey to becoming a cardiac surgeon, the genesis of...

Calcified bifurcation lesions remain one of the toughest challenges in interventional cardiology, combining two high-risk features into one complex scenario.

In this discussion, Dejan Milasinovic, Miroslaw Ferenc, and Mohamed Abdel Wahab explain why this subset deserves dedicated attention. They highlight the critical role of intra-coronary imaging to...

Elliot Smith, Thomas Hovasse and Roberto Garbo discuss a comprehensive, step-by-step approach to CTO interventions, providing structured guidance on navigating CTOs in a safe and effective way.

The discussion begins with angiographic assessment, emphasising the importance of identifying key anatomical features upfront. Based on this evaluation, operators determine...

At EuroPCR 2025, Marianna Adamo and Ralph Stephan von Bardeleben discussed the latest findings on tricuspid valve repair using transcatheter edge-to-edge repair (TEER).

The 2-year results from the TRILUMINATE Pivotal trial showed a significant reduction in tricuspid regurgitation, lasting improvements in quality of life, and a notable...

Simon Redwood and John Forrest exchange insights on the Evolut Low Risk Bicuspid Study, which explores transcatheter aortic valve replacement (TAVR) in younger, low-risk patients with bicuspid aortic valves—an anatomy often excluded from earlier trials.

They review the trial design, patient characteristics, and results, comparing outcomes with...

Tiffany Patterson, Nicolas Van Mieghem, and Philippe Généreux discuss emerging indications for TAVI in 2025. They review recent evidence on asymptomatic severe aortic stenosis, highlighting four randomised trials—RECOVERY, AVATAR, ONLY TAVR, and EVoLVeD—that show TAVI or surgical AVR reduces hospitalisations for heart failure and trends toward...

In this EuroPCR 2025 interview, Davide Capodanno and Woong Chol Kang discuss antithrombotic therapy in patients with acute coronary syndromes, focusing on the design and outcomes of the 4D-ACS trial. They describe the patient population enrolled in the study and introduce the two de-escalation strategies investigated:...

At EuroPCR 2025, Nilesh Pareek and Thomas Keeble discuss the clinical value and future potential of NIRS IVUS, a dual-modality imaging system developed by Nipro that combines intravascular ultrasound with near-infrared spectroscopy.

The Makoto™ system and Dualpro™ catheter allow real-time identification of lipid-rich plaques by providing both...

At EuroPCR 2025, Angela McInerney, Didier Tchétché, and Ole De Backer discuss key results from the SMART and Evolut Low Risk trials. The SMART trial compared balloon-expandable and self-expanding valves in small annulus patients, showing better hemodynamics with the Evolut platform at 2 years. The Evolut...

At EuroPCR 2025, Andreas Baumbach, Christian Juhl Terkelsen and Didier Tchetche reviewed the latest findings from the LANDMARK and Compare-TAVI 1 trials—both focused on the performance of the Myval balloon-expandable valve.

LANDMARK compared Myval and Myval Octacor to leading self-expanding valves in a randomised controlled trial. At...